Jubilant Life Sciences informs about company updates
Date: 30-09-2016Jubilant Life Sciences has informed about issue of rated unsecured high yield bonds by our wholly-owned subsidiary, Jubilant Pharma (a company incorporated under the laws of Singapore), outside India, under Regulations of the US Securities Act of 1933 (the ‘US Securities Act’).
The above information is a part of company’s filings submitted to BSE.